EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Insights into COVID-19 Chemotherapies: Potential and Challenges

Esam Yahya

Journal of Chemistry and Nutritional Biochemistry · 2021

DOI: 10.48185/jcnb.v2i1.168 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Chemistry and Nutritional Biochemistry, 2021. Verfasst von Esam Yahya. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The coronavirus disease 2019 (COVID-19), a newly emerged infectious disease caused by SARS-CoV-2 virus, has recently become pandemic. Although several therapeutic options are currently available for the treatment of COVID-19, no effective antiviral agents have been developed yet. Many countries follow the strategy of keeping the patient in good state and count on his own immune system to develop an effective immune response. Since the beginning of the pandemic, many previous therapeutic options have been used in COVID-19 treatment including antiviral, non-antiviral drugs and convalescent plasma-based therapies. This review delivers comprehensive illustration of the current therapeutic drugs that have been used for COVID-19 treatment all over the world since the pandemic starts.

Zitieren

APA

Yahya, E. (2021). Insights into COVID-19 Chemotherapies: Potential and Challenges. Journal of Chemistry and Nutritional Biochemistry. https://doi.org/10.48185/jcnb.v2i1.168

Vancouver

Yahya E. Insights into COVID-19 Chemotherapies: Potential and Challenges. Journal of Chemistry and Nutritional Biochemistry. 2021. doi:10.48185/jcnb.v2i1.168

BibTeX
@article{Yahya2021,
  author = {Yahya, Esam},
  title = {Insights into COVID-19 Chemotherapies: Potential and Challenges},
  journal = {Journal of Chemistry and Nutritional Biochemistry},
  year = {2021},
  doi = {10.48185/jcnb.v2i1.168}
}
Kostenlos starten →